<DOC>
	<DOC>NCT00556361</DOC>
	<brief_summary>To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.</brief_summary>
	<brief_title>Use of Ketamine Prior to Cardiopulmonary Bypass in Children</brief_title>
	<detailed_description />
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects, Ventricular</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>less than one year of age undergoing cardiac surgery for repair of ventricular septal defect requiring cardiopulmonary bypass not requiring retrogrades cerebral perfusion Downs Syndrome</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>